Molecular Biology Reports

, Volume 39, Issue 4, pp 4351–4358 | Cite as

The LOX-1 3′UTR188CT polymorphism and coronary artery disease in Turkish patients

  • Özlem Kurnaz
  • A. Başak Akadam-Teker
  • Hülya Yilmaz-Aydoğan
  • Atike Tekeli
  • Turgay İsbir


In coronary artery disease (CAD), a potentially reversible factor leading to cardiac death is left ventricular hypertrophy (LVH). The 3′untranslated region (3′UTR) 188CT polymorphism of lectin-like oxidized low-density lipoproteins receptor-1 (LOX-1) gene has been associated with an increased risk for CAD. We aim to investigate, in a Turkish population, whether 3′UTR188CT variation could affect the development of LVH in CAD patients. In a population-based case–control study, we compared 83 cases with CAD and 99 healthy controls for this polymorphism. The LOX-1 3′UTR188CT genotypes were determined by PCR–RFLP technique. LOX-1 3′UTR188 TT genotype was associated with significantly increased systolic blood pressure (P = 0.047) and risk of LVH (P = 0.014, OR: 3.541) when compared with the C allele carriers. In addition, the TT genotype was positively associated with decreased levels of HDL-cholesterol in the control subjects (P = 0.031) and increased levels of VLDL-C in the patient group (P = 0.009). The LOX-1 3′UTR188CT gene polymorphism may predispose to the development of LVH in CAD patients, dependent on blood pressure.


Oxidized LDL receptor-1 Coronary artery disease Left ventricular hypertrophy Polymorphism 



Lectin like oxidized receptor


Oxidized LDL


Coronary artery disease


Left ventricular hypertrophy


Vascular smooth muscle cell


Oxidized LDL receptor-1 gene


3′Untranslated region


Body mass index


Total cholesterol










Systolic blood pressure


Diastolic blood pressure



The present work was supported by the Research Fund of Istanbul University. Project No. T–966/06102006.


  1. 1.
    Vecchione L, Gargiu E, Borgiani P, Predazzi I, Mango R, Romeo F, Magnani M, Novelli G (2007) Genotyping OLR1 gene: a genomic biomarker for cardiovascular diseases. Recent Pat Cardiovasc Drug Discov 2:147–151PubMedCrossRefGoogle Scholar
  2. 2.
    Wilson PW (1994) Established risk factors and coronary artery disease: the framingham study. Am J Hypertens (7 Pt 2):7–12Google Scholar
  3. 3.
    Suzuki T, Kohno H, Hasegawa A, Toshima S, Amaki T, Kurabayashi M, Nagai R, Clinical Trial of Oxidized LDL (CTOL) investigators (2002) Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of coronary artery disease. Clin Biochem 35:347–353PubMedCrossRefGoogle Scholar
  4. 4.
    Chen M, Masaki T, Sawamura T (2002) LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacol Ther 95:89–100PubMedCrossRefGoogle Scholar
  5. 5.
    Freeman MW (1997) Scavenger receptors in atherosclerosis. Curr Opin Hematol 4:41–47PubMedCrossRefGoogle Scholar
  6. 6.
    Tate S (2007) Oxidized low-density lipoprotein receptor, LOX-1, on the endothelial cell-the receptor structure and functions of LOX-1 in atherogenesis. J Biol Macromol 7(2):11–22Google Scholar
  7. 7.
    Steinbrecher UP (1999) Receptors for oxidized low density lipoprotein. Biochim Biophys Acta 1436:279–298PubMedGoogle Scholar
  8. 8.
    Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, Masaki T (1997) An endothelial receptor for oxidized low-density lipoprotein. Nature 386:73–77PubMedCrossRefGoogle Scholar
  9. 9.
    Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G (2006) Lectin-like oxidized low-density lipoprotein receptor-1(LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc Res 69:36–45PubMedCrossRefGoogle Scholar
  10. 10.
    Chen X, Du G (2007) Lectin-like oxidized low-density lipoprotein receptor-1: protein, ligands, expression and pathophysiological significance. Chin Med J (Engl) 120(5):421–426Google Scholar
  11. 11.
    Trabetti E, Biscuola M, Cavallari U, Malerba G, Girelli D, Olivieri O, Martinelli N, Corrocher R, Pignatti PF (2006) On the association of the oxidized LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction or coronary artery disease. E J Hum Genet 14:127–130Google Scholar
  12. 12.
    Sentinelli F, Filippi E, Fallarino M, Romeo S, Fanelli M, Buzzetti R, Berni A, Baroni MG (2006) The 3′UTR C > T polymorphism of the oxidized LDL receptor 1 (OLR1) gene does not associate with coronary artery disease in Italian CAD patients or with the severity of coronary disease. Nut Metab Cardiovasc Dis 16:345–352CrossRefGoogle Scholar
  13. 13.
    Ellis TJ (2006) LOX-1 genotype, dietary fat intake, and aerobic exercise training: influence on endothelial function, oxidative stress, lipoprotein-lipids, and soluble LOX-1. Thesis (Phd), University of Maryland, College ParkGoogle Scholar
  14. 14.
    Mango R, Clementi F, Borgiani P, Forleo GB, Federici M, Contino G, Giardina E, Garza L, Fahdi IE, Lauro R, Mehta JL, Novelli G, Romeo F (2003) Association of single nucleotide polymorphisms in the oxidized LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. J Med Genet 40:933–936PubMedCrossRefGoogle Scholar
  15. 15.
    Hattori H, Sonoda A, Sato H, Ito D, Tanahashi N, Murata M, Saito I, Watanabe K, Suzuki N (2006) G501C polymorphism of oxidized LDL receptor gene (OLR1) and ischemic stroke. Brain Res 1121:246–249PubMedCrossRefGoogle Scholar
  16. 16.
    Chen Q, Reis SE, Kammerer C, Craig WY, LaPierre SE, Zimmer EL, McNamara DM, Pauly DF, Sharaf B, Holubkov R, Bairey Merz CN, Sopko G, Bontempo F, Kamboh MI (2003) Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease. Circulation 107:3146–3151PubMedCrossRefGoogle Scholar
  17. 17.
    Ohmori R, Momiyama Y, Nagano M, Taniguchi H, Egashira T, Yonemura A, Nakamura H, Kondo K, Ohsuzu F (2004) An oxidized low-density lipoprotein receptor gene variant is inversely associated with the severity of coronary artery disease. Clin Cardiol 27(11):641–644PubMedCrossRefGoogle Scholar
  18. 18.
    Cuspidi C, Vaccarella A, Negri F, Sala C (2010) Resistant hypertension and left ventricular hypertrophy: an overview. J Am Soc Hypertens 4(6):319–324PubMedCrossRefGoogle Scholar
  19. 19.
    Hu C, Dandapat A, Sun L, Marwali MR, Inoue N, Sugawara F, Inoue K, Kawase Y, Jishage K, Suzuki H, Hermonat PL, Sawamura T, Mehta JL (2008) Modulation of angiotensin II-mediated hypertension and cardiac remodeling by lectin-like oxidized low-density lipoprotein receptor-1 deletion. Hypertension 52(3):556–562PubMedCrossRefGoogle Scholar
  20. 20.
    Sahn DJ, De Maria A, Kisslo J, The Committee on M-Mode Standardization of the American Society of Echocardiography et al (1978) Recommendations regarding quantitation in M-mode echocardiography: result of a survey of echocardiographic measurements. Circulation 58:1072–1083PubMedGoogle Scholar
  21. 21.
    Miller SA, Dykes DD, Poleskey HS (1988) Simples salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMedCrossRefGoogle Scholar
  22. 22.
    Puccetti L, Pasqui AL, Bruni F, Pastorelli M, Ciani F, Palazzuoli A et al (2007) Lectin-like oxidized-LDL receptor-1 (LOX-1) polymorphisms influence cardiovascular events rate during statin treatment. Int J Cardiol 119(1):41–47PubMedCrossRefGoogle Scholar
  23. 23.
    Brinkley TE, Kume N, Mitsuoka H, Brown MD, Phares DA, Ferrell RE, Kita T, Hagberg JM (2008) Variation in the human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1) gene is associated with plasma soluble LOX-1 levels. Exp Physiol 93(9):1085–1090PubMedCrossRefGoogle Scholar
  24. 24.
    Knowles JW, Assimes TL, Boerwinkle E, Fortmann SP, Go A, Grove ML, Hlatky M, Iribarren C, Li J, Myers R, Risch N, Sidney S, Southwick A, Volcik KA, Quertermous T (2008) Failure to replicate an association of SNPs in the oxidized LDL receptor gene (OLR1) with CAD. BMC Med Genet 9:23Google Scholar
  25. 25.
    Frohlich E, González A, Díez J (2011) Hypertensive left ventricular hypertrophy risk: beyond adaptive cardiomyocytic hypertrophy. J Hypertens 29(1):17–26PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  • Özlem Kurnaz
    • 1
  • A. Başak Akadam-Teker
    • 1
  • Hülya Yilmaz-Aydoğan
    • 1
  • Atike Tekeli
    • 2
  • Turgay İsbir
    • 1
  1. 1.Department of Molecular Medicine, The Institute of Experimental MedicineIstanbul UniversityIstanbulTurkey
  2. 2.Department of Cardiovascular SurgeryMarmara University School of MedicineIstanbulTurkey

Personalised recommendations